Wuxi Biologics (Cayman) (2269) Ownership - Who Owns Wuxi Biologics (Cayman)?

55 Followers

Wuxi Biologics (Cayman) (2269) Ownership Overview

6.22%

Mutual Funds

0.02% Other Institutional Investors

8.16% ETFs

85.60% Public Companies and

Individual Investors

The ownership structure of Wuxi Biologics (Cayman) (HK:2269) stock is a mix of institutional, retail, and individual investors. Approximately 14.40% of the company’s stock is owned by Institutional Investors, and 85.60% is owned by Public Companies and Individual Investors.

The ownership structure of Wuxi Biologics (Cayman) (HK:2269) stock is a mix of institutional, retail, and individual investors. Approximately 8.18% of the company’s stock is owned by Institutional Investors, 6.22% is owned by Insiders, and 85.60% is owned by Public Companies and Individual Investors.

Top Shareholders

# of Shares	Type	% Holding	Value
143,295,011	Institution	3.46%	618,461,267
63,580,794	Institution	1.54%	274,414,707
56,233,418	Institution	1.36%	242,703,432
53,508,500	Institution	1.29%	230,942,686
50,326,374	Institution	1.22%	217,208,630
27,708,714	Institution	0.67%	119,590,810
27,132,010	Institution	0.66%	117,101,755
19,776,500	Institution	0.48%	85,355,374
16,196,006	Institution	0.39%	69,901,962
15,052,654	Institution	0.36%	64,967,255

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
56,233,418	Institution	1.36%	242,703,432
53,508,500	Institution	1.29%	230,942,686
50,326,374	Institution	1.22%	217,208,630
19,776,500	Institution	0.48%	85,355,374
16,196,006	Institution	0.39%	69,901,962
10,443,602	Institution	0.25%	45,074,586
9,548,222	Institution	0.23%	41,210,126
6,486,644	Institution	0.16%	27,996,356
4,403,000	Institution	0.11%	19,003,348
4,377,000	Institution	0.11%	18,891,132

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard FTSE Emerging Markets ETF	47,928,566	Institution	1.16%	246,076,305
iShares Core MSCI Emerging Markets ETF	39,318,000	Institution	0.95%	166,851,333
JPMorgan BetaBuilders Developed Asia ex-Japan ETF	10,089,500	Institution	0.24%	43,583,991
iShares MSCI Emerging Markets ETF	8,691,000	Institution	0.21%	37,542,834
iShares MSCI China ETF	8,674,000	Institution	0.21%	38,123,905
Vanguard FTSE All-World ex-US Index Fund	7,926,112	Institution	0.19%	40,694,457
iShares MSCI EM SRI UCITS ETF	5,652,500	Institution	0.14%	25,621,214
SPDR Portfolio Emerging Markets ETF	5,334,500	Institution	0.13%	23,235,522
iShares MSCI China UCITS ETF USD	5,125,500	Institution	0.12%	23,232,469
First Trust WCM International Equity ETF	4,843,728	Institution	0.12%	20,555,027

FAQ

Who Owns Wuxi Biologics (Cayman) Inc. (HK:2269)?

Currently, no data Available

What percentage of Wuxi Biologics (Cayman) Inc. (HK:2269) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.02% of Wuxi Biologics (Cayman) Inc. (HK:2269) stock is held by institutional investors.

What percentage of Wuxi Biologics (Cayman) Inc. (HK:2269) stock is held by retail investors?

According to the latest TipRanks data, approximately 85.60% of Wuxi Biologics (Cayman) Inc. (HK:2269) stock is held by retail investors.

Who owns the most shares of Wuxi Biologics (Cayman) Inc. (HK:2269)?

iShares owns the most shares of Wuxi Biologics (Cayman) Inc. (HK:2269).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.